Area of research
Infectious Diseases · Immunology
Research interest
Research interests include COVID-19 Clinical Research Studies, SARS-CoV-2 and COVID-19 Research, Immunotherapy and Immune Responses, and vaccines and immunoinformatics approaches.
Phase I/II trial of a peptide-based COVID-19 T-cell activator in patients with B-cell deficiency
The oncogenic fusion protein DNAJB1-PRKACA can be specifically targeted by peptide-based immunotherapy in fibrolamellar hepatocellular carcinoma
Phase I/II trial of a peptide-based COVID-19 T-cell activator in patients with B-cell deficiency
A COVID-19 peptide vaccine for the induction of SARS-CoV-2 T cell immunity
T cell and antibody kinetics delineate SARS-CoV-2 peptides mediating long-term immune responses in COVID-19 convalescent individuals
Preexisting and Post–COVID-19 Immune Responses to SARS-CoV-2 in Patients with Cancer
Phase I Trial of a Multi-Peptide COVID-19 Vaccine for the Induction of SARS-CoV-2 T-Cell Immunity
SARS-CoV-2-derived peptides define heterologous and COVID-19-induced T cell recognition
Differential Kinetics of T Cell and Antibody Responses Delineate Dominant T Cell Epitopes in Long-Term Immunity after COVID-19
The HLA ligandome landscape of chronic myeloid leukemia delineates novel T-cell epitopes for immunotherapy
The HLA Ligandome Landscape of Chronic Myeloid Leukemia Delineates Novel T-Cell Epitopes for Immunotherapy